Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose versus divided-dose gonadotropin-releasing hormone agonist in ICSI outcomes
IRCT20240426061578N1Phase 3Completed
- Sponsor
- Avicenna Research Institute
- Start
- Jun 2024
- Countries
- 1
01
Overview
Phase 3 trial of gonadotropin-releasing hormone agonist in infertility (2 arms), sponsored by Avicenna Research Institute. Primary endpoint: ICSI clinical outcomes. Started Jun 2024; status: completed.
02
Drugs
gonadotropin-releasing hormone agonist
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20240426061578N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240426061578N1.